Cargando…
Comment in Response to “Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina”
Autores principales: | Westhoff, Mike-Andrew, Baisch, Tim, Herbener, Verena J., Karpel-Massler, Georg, Debatin, Klaus-Michael, Strobel, Hannah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235879/ https://www.ncbi.nlm.nih.gov/pubmed/32326020 http://dx.doi.org/10.3390/biomedicines8040093 |
Ejemplares similares
-
Considering the Experimental Use of Temozolomide in Glioblastoma Research
por: Herbener, Verena J., et al.
Publicado: (2020) -
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019) -
The limitations of targeting MEK signalling in Glioblastoma therapy
por: Selvasaravanan, Karthika D., et al.
Publicado: (2020) -
Killing Me Softly—Future Challenges in Apoptosis Research
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014) -
Targeting super-enhancers reprograms glioblastoma central carbon metabolism
por: Nguyen, Trang T.T., et al.
Publicado: (2021)